ConductScience.org, home

Trial · NCT01402882

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe primary outcome is death in hospital in patients recruited within 3 hours and cause of death will be described.within 28 days of injury
Secondary(a) Vascular occlusive events (myocardial infarction, stroke, pulmonary embolism, clinical evidence of deep vein thrombosis)Prior death, discharge or 28 days
Secondary(b) In hospital disability assessed using the Disability Rating Scale and Patient Orientated OutcomePrior death, discharge or 28 days
Secondary(c) SeizuresPrior death, discharge or day 28
Secondary(d) Neurosurgical interventionprior death, discharge or day 28
Secondary(e) Days in intensive careprior death, discharge or day 28
Secondary(f) Other adverse eventsprior death, discharge or day 28
OtherCRASH-3 IBS: Primary outcome - the total volume of intracranial haemorrhage1) CT scan done before receipt of trial treatment; (2) CT scan done after receipt of trial treatment (up to 28 days after randomisation)
OtherFrequency of progressive haemorrhage: number of patients with a post-randomisation CT scan with total haemorrhage volume of more than 25% of the volume on the pre-randomisation scan1) CT scan done before receipt of trial treatment; (2) CT scan done after receipt of trial treatment (up to 28 days after randomisation)
OtherFrequency of delayed haemorrhage:1) CT scan done before receipt of trial treatment; (2) CT scan done after receipt of trial treatment (up to 28 days after randomisation)
OtherNew focal ischaemic lesions:1) CT scan done before receipt of trial treatment; (2) CT scan done after receipt of trial treatment (up to 28 days after randomisation)
Other• Total volume of intracranial bleeding in patients who undergo surgical evacuation of haemorrhage after randomisation1) CT scan done before receipt of trial treatment; (2) CT scan done after receipt of trial treatment (up to 28 days after randomisation)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01402882/registered